General practitioners and St. John's Wort: A question of regulation or knowledge?

Complementary Therapies in Medicine

Volumn 15, Issue 2, 2007, Pages 142-148

  McGarry, H ^a   Pirotta, M ^a   Hegarty, K ^a   Gunn, J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Depression; General practice; Hypericum perforatum; Regulation

Indexed keywords

ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAMAZEPINE; DIGOXIN; HERBACEOUS AGENT; HYPERICUM PERFORATUM EXTRACT; NON PRESCRIPTION DRUG; ORAL CONTRACEPTIVE AGENT; PARACETAMOL; SEROTONIN UPTAKE INHIBITOR; WARFARIN;

ADULT; AGRANULOCYTOSIS; ALTERNATIVE MEDICINE; ARTICLE; AUSTRALIA; CLINICAL EDUCATION; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DIZZINESS; DRUG CROSS REACTIVITY; DRUG ERUPTION; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; GENERAL PRACTICE; GENERAL PRACTITIONER; HERBAL MEDICINE; HUMAN; HYPERICUM PERFORATUM; INSOMNIA; KNOWLEDGE; MALE; PHOTOSENSITIVITY; PRESCRIPTION; SEDATION; SEXUAL DYSFUNCTION; SIDE EFFECT;

AUSTRALIA; DEPRESSION; FAMILY PRACTICE; FEMALE; HEALTH CARE SURVEYS; HUMANS; HYPERICUM; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PHYTOTHERAPY; PLANT PREPARATIONS; SEVERITY OF ILLNESS INDEX;

EID: 34249681450     PISSN: 09652299     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctim.2006.02.002     Document Type: Article

References (31)

1. Schrader E. Equivalence of St John's Wort extract (Ze 117) and fluoxetine: a randomized, controlled study in mild-moderate depression. Int Clin Psychopharmacol 15 (2000) 61-68
2. Gaster B., and Holroyd J. St John's Wort for depression: a systematic review. Arch Intern Med 160 (2000) 152-156
3. Linde K., Mulrow C., Berner M., and Egger M. St John's Wort for depression. The Cochrane Library (2006) [Review]
4. Gelenberg A., Shelton R., Crits-Cristoph P., et al. The effectiveness of St. John's Wort in major depressive disorder: a naturalistic phase 2 follow-up in which nonresponders were provided with alternate medication. J Clin Psychiatry 65 (2004) 1114-1119
5. Whiskey E., Werneke U., and Taylor D. A systematic review and meta-analysis of Hypericum perforatum in depression: a comprehensive clinical review. Int Clin Psychopharmacol 16 (2001) 239-252
6. Shelton R., Keller M., Gelenberg A., et al. Effectiveness of St John's Wort in major depression: a randomized controlled trial. JAMA 285 (2001) 1978-1986
7. Davidson J., Gadde K., Fairbank J., et al. Effect of Hypericum perforatum (St. John's Wort) in major depressive disorder: a randomized controlled trial. JAMA 287 (2002) 1807-1814
8. Szegedi A., Kohnen R., Dienel A., and Kieser M. Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St. John's Wort): randomised controlled double blind non-inferiority trial versus paroxetine. BMJ 330 (2005) 503
9. Hammerness P., Basch E., Ulbricht C., et al. St. John's Wort: a systemic review of adverse effects and drug interactions for the consultation psychiatrist. Psychosomatics 44 (2003) 271-282
10. Johne A., Brockmoller J., Bauer S., Maurer A., Langheinrich M., and Roots I. Pharmacokinetic interaction of digoxin with an herbal extract from St John's Wort (Hypericum perforatum). Clin Pharmacol Ther 66 (1999) 338-345
11. Piscitelli S., Burnstein A., Chaitt D., Alfaro R., and Falloon J. Indinavir concentrations and St. John's Wort. Lancet 355 (2000) 547-548
12. Ruschitzka F., Meier P., Turina M., Luscher T., and Noll G. Acute heart transplant rejection due to St. John's Wort. Lancet 355 (2000) 548-549
13. Hall S., Wang Z., Huang S., et al. The interaction between St. John's Wort and an oral contraceptive. Clin Pharmacol Ther 74 (2003) 525-535
14. Katon W., Robinson P., Von Korff M., et al. A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatry 53 (1996) 924-932
15. Pirotta M., Cohen M., Kotsirilos V., and Farish S. Complementary therapies: have they become accepted in general practice?. Med J Aust 172 (2000) 105-109
16. MacLennan A., Wilson D., and Taylor A. The escalating cost and prevalence of alternative medicine. Prev Med 35 (2002) 166-173
17. Smith L., Ernst E., Ewings P., Myers P., and Smith C. Co-ingestion of herbal medicines and warfarin. Br J Gen Pract 54 (2004) 439-441
18. Expert Committee on Complementary Medicines in the Health System. Complementary medicines in the Australian health system (2003), Department of Health and Ageing, Canberra
19. Wang Z., Lin S., and Hu M. Contents of hypericin and pseudohypericin in five commercial products of St John's Wort (Hypericum perforatum). J Sci Food Agric 84 (2004) 395-397
20. National Collaborating Centre for Mental Health. Depression: management of depression in primary and secondary care (2004), National Institute for Clinical Excellence, London p. 227-34
21. McGarry H., Hegarty K., and Gunn J. How do Victorian general practitioners manage patients with depression?. Aust Fam Physician 34 (2005) 603-606
22. Department of Health. New Advice on St. John's Wort. Department of Health (UK). March 3, 2000. Available at: http://www.dh.gov.uk/PublicationsAndStatistics/PressReleases/PressReleasesNotices/fs/en?CONTENT_ID=4002579&chk=ILhcV4. Accessed, February 18, 2005.
23. Complementary Medicines Evaluation Committee. Complementary Medicines Evaluation Committee public recommendation summary. Therapeutic Goods Administration. May 26, 2000. Available at: http://www.tga.gov.au/docs/html/cmec/cmecdr20.htm. Accessed February 18, 2005.
24. Ernst E. Complementary medicine: implications for informed consent in general practice. Br J Gen Pract (2004) 82-83
25. Medicines Control Agency. Adverse drug reactions online information tracking drug analysis print: Hypericum perforatum. Medicines Control Agency. Available at: www.mca.gov.uk/. Accessed March 3, 2005.
26. Select Committee on Science and Technology. Select Committee on Science and Technology 6th Report. House of Lords. Available at: http://www.chiro.org/alt_med_abstracts/FULL/House_of_Lords/CHAPTER_I.html#a4. Accessed June 21, 2004.
27. Lim M., Sadarangani P., Chan H., and Heng J. Complementary and alternative medicine use in multiracial Singapore. Complement Ther Med 13 (2005) 16-24
28. Australian Institute of Health and Welfare. Medical labour force 1999. Australian Institute of Health and Welfare. Available at: http://www.aihw.gov.au/publications/index.cfm?type=detail&id=8391. Accessed August 18, 2003.
29. Harding J. The supply and distribution of general practitioners. In: Calcino G., MacIsaac P., and Northrop M. (Eds). General practice in Australia: 2000 (2000), Commonwealth Department of Health and Aged Care, Canberra 41-73
30. MIMS Annual. 26th ed. St Leonards: Medimedia Australia Pty Ltd; 2002.
31. Brazier N., and Mitchell A. Understanding drug-herb interactions. Pharmacoepidemiol Drug Saf 12 (2003) 427-430